Bb Biotech as of Dec. 31, 2016
Portfolio Holdings for Bb Biotech
Bb Biotech holds 29 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 14.8 | $400M | 3.5M | 115.75 | |
| Incyte Corporation (INCY) | 14.4 | $389M | 3.9M | 100.27 | |
| Ionis Pharmaceuticals (IONS) | 12.2 | $331M | 6.9M | 47.83 | |
| Gilead Sciences (GILD) | 7.4 | $199M | 2.8M | 71.61 | |
| Radius Health | 6.1 | $166M | 4.4M | 38.03 | |
| Alexion Pharmaceuticals | 5.6 | $150M | 1.2M | 122.35 | |
| Tesaro | 4.8 | $131M | 975k | 134.48 | |
| Neurocrine Biosciences (NBIX) | 4.5 | $122M | 3.2M | 38.70 | |
| Agios Pharmaceuticals (AGIO) | 4.3 | $117M | 2.8M | 41.73 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.9 | $104M | 1.4M | 73.67 | |
| Regeneron Pharmaceuticals (REGN) | 3.3 | $90M | 245k | 367.09 | |
| Halozyme Therapeutics (HALO) | 2.8 | $75M | 7.6M | 9.88 | |
| Sage Therapeutics (SAGE) | 1.9 | $52M | 1.0M | 51.06 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $45M | 1.2M | 37.44 | |
| Myovant Sciences | 1.5 | $40M | 3.2M | 12.44 | |
| Macrogenics (MGNX) | 1.4 | $39M | 1.9M | 20.44 | |
| Kite Pharma | 1.3 | $36M | 800k | 44.84 | |
| Juno Therapeutics | 1.3 | $35M | 1.9M | 18.85 | |
| Alder Biopharmaceuticals | 1.3 | $35M | 1.7M | 20.80 | |
| Intercept Pharmaceuticals In | 1.0 | $28M | 256k | 108.65 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $24M | 1.6M | 15.09 | |
| Prothena (PRTA) | 0.6 | $17M | 350k | 49.19 | |
| Avexis | 0.6 | $17M | 353k | 47.73 | |
| Esperion Therapeutics (ESPR) | 0.6 | $16M | 1.3M | 12.52 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $11M | 1.0M | 10.40 | |
| Novavax | 0.4 | $11M | 8.3M | 1.26 | |
| Puma Biotechnology (PBYI) | 0.3 | $7.4M | 242k | 30.70 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $7.5M | 683k | 10.91 | |
| Achillion Pharmaceuticals | 0.2 | $5.3M | 1.3M | 4.13 |
